JP2025502712A5 - - Google Patents

Info

Publication number
JP2025502712A5
JP2025502712A5 JP2024537905A JP2024537905A JP2025502712A5 JP 2025502712 A5 JP2025502712 A5 JP 2025502712A5 JP 2024537905 A JP2024537905 A JP 2024537905A JP 2024537905 A JP2024537905 A JP 2024537905A JP 2025502712 A5 JP2025502712 A5 JP 2025502712A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
alkoxy
halogen
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025502712A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/053308 external-priority patent/WO2023121992A1/en
Publication of JP2025502712A publication Critical patent/JP2025502712A/ja
Publication of JP2025502712A5 publication Critical patent/JP2025502712A5/ja
Pending legal-status Critical Current

Links

JP2024537905A 2021-12-22 2022-12-19 シクロプロピル化合物 Pending JP2025502712A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163292482P 2021-12-22 2021-12-22
US63/292,482 2021-12-22
PCT/US2022/053308 WO2023121992A1 (en) 2021-12-22 2022-12-19 Cyclopropyl compounds

Publications (2)

Publication Number Publication Date
JP2025502712A JP2025502712A (ja) 2025-01-28
JP2025502712A5 true JP2025502712A5 (https=) 2025-12-12

Family

ID=85150131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537905A Pending JP2025502712A (ja) 2021-12-22 2022-12-19 シクロプロピル化合物

Country Status (5)

Country Link
US (1) US20240336571A1 (https=)
EP (1) EP4452944A1 (https=)
JP (1) JP2025502712A (https=)
CN (1) CN118510757A (https=)
WO (1) WO2023121992A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200024963A1 (it) * 2022-12-05 2024-06-05 Angelini Pharma S P A Composti attivatori dei canali potassio Kv7.2/Kv7.3
CN116589423B (zh) * 2023-05-18 2026-01-23 四川省医学科学院·四川省人民医院 苯环丙脲类化合物、其制备方法及其应用
WO2025252599A1 (en) * 2024-06-04 2025-12-11 Angelini Pharma S.P.A. Activating compounds of potassium channels kv7.2/kv7.3
WO2025252600A1 (en) * 2024-06-04 2025-12-11 Angelini Pharma S.P.A. Activating compounds of potassium channels kv7.2/kv7.3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
HRP20240012T1 (hr) 2019-02-06 2024-03-29 Eli Lilly And Company Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)uree kao kcnq potencijatori
AU2020284742B2 (en) * 2019-05-28 2026-03-05 Mankind Pharma Ltd. Novel compounds for inhibition of Janus Kinase 1

Similar Documents

Publication Publication Date Title
JP2025502712A5 (https=)
JP2024050527A5 (https=)
JP2021523221A5 (https=)
JP2014507455A5 (https=)
JP2022510683A5 (https=)
JP2015509534A5 (https=)
RU2015149008A (ru) 19-нор c3, 3-дизамещенные c21-n-пиразолильные стероиды и способы их применения
JP2022534704A5 (https=)
RU2020131091A (ru) Композиции и способы для лечения расстройств цнс
JP2017531020A5 (https=)
JP2022510925A5 (https=)
JP2023552610A5 (https=)
JP2016513076A5 (https=)
JP2022534709A5 (https=)
JP2024542881A5 (https=)
US20230134672A1 (en) Ketorolaco derivative, pharmaceutical composition and preparation method therefor and use thereof
JP2005519073A5 (https=)
EP4471019A1 (en) 3-[(benzo[d][1,3]dioxolane-4-yl)oxy]propylamine hydrochloride, optical isomer and crystal thereof, and preparation method therefor
JP2013542267A5 (https=)
JP2023512664A5 (https=)
JP2025503448A5 (https=)
JP2022529309A5 (https=)
JP2014523888A5 (https=)
JP2017525684A5 (https=)
JP2018523644A5 (https=)